Carotid stenting offers safe option in the elderly
Carotid artery stenting can be performed safely in patients 80 years or older, according to study results released at the 2006 American Society of Interventional and Therapeutic Neuroradiology meeting.
Drs. Italo Linfante and Ajay Wakhloo, interventional neuroradiologists from the University of Massachusetts, enrolled 178 patients from 2001 to 2004, 24 of whom were 80 years or older. The sample included more than 70% of symptomatic patients labeled moderately to severely ill. Half presented with severe coronary artery disease. All patients underwent carotid artery stenting, in some cases with distal protection devices. Outcomes revealed a procedural success rate of 100% with almost negligible complications, no deaths, and no reblockage at one-, six-, and 12-month follow-up.
Although carotid artery stenting in elderly patients remains controversial, the study outcomes validated its effectiveness and efficacy, researchers said.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
